BIO logo

Bio-Rad Laboratories (BIO) Long Term Liabilities

Annual Total Long Term Liabilities

$2.33 B
-$708.10 M-23.33%

December 31, 2024


Summary


Performance

BIO Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBIObalance sheetmetrics:

Quarterly Long Term Liabilities

$2.33 B
-$290.67 M-11.10%

December 31, 2024


Summary


Performance

BIO Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBIObalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

BIO Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-23.3%-24.8%
3 y3 years-32.2%-29.9%
5 y5 years+72.6%-29.9%

BIO Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-32.2%at low-34.3%at low
5 y5-year-32.2%+72.6%-41.4%+72.6%
alltimeall time-32.2%>+9999.0%-41.4%>+9999.0%

Bio-Rad Laboratories Long Term Liabilities History

DateAnnualQuarterly
Dec 2024
$2.33 B(-23.3%)
$2.33 B(-11.1%)
Sep 2024
-
$2.62 B(+8.0%)
Jun 2024
-
$2.42 B(-21.7%)
Mar 2024
-
$3.09 B(+1.9%)
Dec 2023
$3.04 B(-8.5%)
$3.04 B(+3.9%)
Sep 2023
-
$2.92 B(-0.9%)
Jun 2023
-
$2.95 B(-11.0%)
Mar 2023
-
$3.31 B(-0.1%)
Dec 2022
$3.32 B(-3.4%)
$3.32 B(+9.3%)
Sep 2022
-
$3.03 B(-3.5%)
Jun 2022
-
$3.15 B(-11.2%)
Mar 2022
-
$3.54 B(+3.2%)
Dec 2021
$3.43 B(+39.5%)
$3.43 B(-13.5%)
Sep 2021
-
$3.97 B(+35.3%)
Jun 2021
-
$2.94 B(+8.2%)
Mar 2021
-
$2.71 B(+10.3%)
Dec 2020
$2.46 B(+82.5%)
$2.46 B(+11.4%)
Sep 2020
-
$2.21 B(+21.6%)
Jun 2020
-
$1.82 B(+19.4%)
Mar 2020
-
$1.52 B(+12.9%)
Dec 2019
$1.35 B(+18.3%)
$1.35 B(-16.4%)
Sep 2019
-
$1.61 B(-6.0%)
Jun 2019
-
$1.71 B(+10.3%)
Mar 2019
-
$1.55 B(+36.4%)
Dec 2018
$1.14 B(+35.7%)
$1.14 B(-16.5%)
Sep 2018
-
$1.37 B(+4.6%)
Jun 2018
-
$1.30 B(+2.7%)
Mar 2018
-
$1.27 B(+51.3%)
Dec 2017
$840.07 M(+5.0%)
$840.07 M(-3.5%)
Sep 2017
-
$870.83 M(-0.7%)
Jun 2017
-
$877.35 M(+4.7%)
Mar 2017
-
$837.80 M(+4.7%)
Dec 2016
$800.02 M(+2.8%)
$800.02 M(-8.5%)
Sep 2016
-
$874.32 M(+2.9%)
Jun 2016
-
$849.67 M(+5.1%)
Mar 2016
-
$808.08 M(+3.9%)
Dec 2015
$777.86 M(+9.7%)
$777.86 M(-2.9%)
Sep 2015
-
$801.43 M(+5.1%)
Jun 2015
-
$762.55 M(+7.3%)
Mar 2015
-
$710.80 M(+0.2%)
Dec 2014
$709.36 M(-0.7%)
$709.36 M(+0.5%)
Sep 2014
-
$705.51 M(-4.3%)
Jun 2014
-
$737.56 M(+1.4%)
Mar 2014
-
$727.52 M(+1.8%)
Dec 2013
$714.60 M(-25.2%)
$714.60 M(+3.1%)
Sep 2013
-
$693.28 M(-29.3%)
Jun 2013
-
$980.63 M(+0.2%)
Mar 2013
-
$978.85 M(+2.4%)
Dec 2012
$955.56 M(+7.0%)
$955.56 M(+2.3%)
Sep 2012
-
$933.87 M(+3.9%)
Jun 2012
-
$899.22 M(-0.5%)
Mar 2012
-
$903.75 M(+1.2%)
Dec 2011
$893.31 M(+4.4%)
$893.31 M(+3.8%)
Sep 2011
-
$860.82 M(-1.7%)
Jun 2011
-
$875.49 M(+0.9%)
Mar 2011
-
$867.69 M(+1.4%)
Dec 2010
$855.62 M(+2.3%)
$855.62 M(+1.5%)
Sep 2010
-
$843.38 M(+1.0%)
Jun 2010
-
$834.90 M(-1.5%)
Mar 2010
-
$847.78 M(+1.3%)
Dec 2009
$836.67 M(+52.5%)
$836.67 M(+0.2%)
Sep 2009
-
$834.84 M(+0.2%)
Jun 2009
-
$833.21 M(+54.0%)
Mar 2009
-
$541.13 M(-1.4%)
Dec 2008
$548.59 M(-6.3%)
$548.59 M(+1.0%)
Sep 2008
-
$543.31 M(-0.1%)
Jun 2008
-
$544.10 M(-1.7%)
Mar 2008
-
$553.33 M(-5.5%)
Dec 2007
$585.74 M(+28.1%)
$585.74 M(+22.1%)
Sep 2007
-
$479.68 M(+0.8%)
Jun 2007
-
$476.10 M(+0.4%)
Mar 2007
-
$474.29 M(+3.8%)
Dec 2006
$457.10 M
$457.10 M(-0.1%)
Sep 2006
-
$457.58 M(+0.1%)
DateAnnualQuarterly
Jun 2006
-
$456.90 M(+0.9%)
Mar 2006
-
$453.00 M(+0.8%)
Dec 2005
$449.37 M(-2.2%)
$449.37 M(-6.0%)
Sep 2005
-
$477.80 M(+1.0%)
Jun 2005
-
$473.08 M(-0.6%)
Mar 2005
-
$476.15 M(+3.7%)
Dec 2004
$459.36 M(+78.4%)
$459.36 M(+72.6%)
Sep 2004
-
$266.16 M(-0.4%)
Jun 2004
-
$267.10 M(+3.5%)
Mar 2004
-
$258.05 M(+0.2%)
Dec 2003
$257.54 M(+122.8%)
$257.54 M(+10.1%)
Sep 2003
-
$234.02 M(+117.4%)
Jun 2003
-
$107.66 M(-0.5%)
Mar 2003
-
$108.20 M(-6.4%)
Dec 2002
$115.61 M(-42.5%)
$115.61 M(-22.9%)
Sep 2002
-
$149.91 M(-6.6%)
Jun 2002
-
$160.51 M(-14.3%)
Mar 2002
-
$187.37 M(-6.8%)
Dec 2001
$201.04 M(-5.3%)
$201.04 M(+1.8%)
Sep 2001
-
$197.49 M(-2.8%)
Jun 2001
-
$203.10 M(-4.2%)
Mar 2001
-
$212.07 M(-0.1%)
Dec 2000
$212.35 M(-13.8%)
$212.35 M(-4.2%)
Sep 2000
-
$221.64 M(-11.9%)
Jun 2000
-
$251.46 M(-5.6%)
Mar 2000
-
$266.41 M(+8.2%)
Dec 1999
$246.30 M(+341.4%)
$246.30 M(+394.6%)
Sep 1999
-
$49.80 M(-13.1%)
Jun 1999
-
$57.30 M(-2.6%)
Mar 1999
-
$58.80 M(+5.4%)
Dec 1998
$55.80 M(+2.6%)
$55.80 M(+1.1%)
Sep 1998
-
$55.20 M(-15.1%)
Jun 1998
-
$65.00 M(+2.0%)
Mar 1998
-
$63.70 M(+17.1%)
Dec 1997
$54.40 M(+143.9%)
$54.40 M(+162.8%)
Sep 1997
-
$20.70 M(+14.4%)
Jun 1997
-
$18.10 M(-11.3%)
Mar 1997
-
$20.40 M(-8.5%)
Dec 1996
$22.30 M(-41.6%)
$22.30 M(-35.7%)
Sep 1996
-
$34.70 M(0.0%)
Jun 1996
-
$34.70 M(-10.3%)
Mar 1996
-
$38.70 M(+1.3%)
Dec 1995
$38.20 M(-13.2%)
$38.20 M(-11.8%)
Sep 1995
-
$43.30 M(+6.9%)
Jun 1995
-
$40.50 M(-4.5%)
Mar 1995
-
$42.40 M(-3.6%)
Dec 1994
$44.00 M(-29.3%)
$44.00 M(-3.3%)
Sep 1994
-
$45.50 M(-11.8%)
Jun 1994
-
$51.60 M(-12.2%)
Mar 1994
-
$58.80 M(-5.5%)
Dec 1993
$62.20 M(-7.4%)
$62.20 M(+45.7%)
Sep 1993
-
$42.70 M(-5.1%)
Jun 1993
-
$45.00 M(-38.2%)
Mar 1993
-
$72.80 M(+8.3%)
Dec 1992
$67.20 M(-4.3%)
$67.20 M(+10.2%)
Sep 1992
-
$61.00 M(-3.9%)
Jun 1992
-
$63.50 M(-9.5%)
Mar 1992
-
$70.20 M(0.0%)
Dec 1991
$70.20 M(+47.8%)
$70.20 M(+12.9%)
Sep 1991
-
$62.20 M(+24.9%)
Jun 1991
-
$49.80 M(+1.6%)
Mar 1991
-
$49.00 M(+3.2%)
Dec 1990
$47.50 M(+15.3%)
$47.50 M(-0.2%)
Sep 1990
-
$47.60 M(+13.1%)
Jun 1990
-
$42.10 M(-0.5%)
Mar 1990
-
$42.30 M(+2.7%)
Dec 1989
$41.20 M(-2.8%)
$41.20 M(-1.9%)
Sep 1989
-
$42.00 M(-11.0%)
Jun 1989
-
$47.20 M(+11.3%)
Dec 1988
$42.40 M(+16.2%)
$42.40 M(+16.2%)
Dec 1987
$36.50 M(+42.6%)
$36.50 M(+42.6%)
Dec 1986
$25.60 M(+44.6%)
$25.60 M(+44.6%)
Dec 1985
$17.70 M(-37.0%)
$17.70 M(-37.0%)
Dec 1984
$28.10 M
$28.10 M

FAQ

  • What is Bio-Rad Laboratories annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Bio-Rad Laboratories?
  • What is Bio-Rad Laboratories annual total long term liabilities year-on-year change?
  • What is Bio-Rad Laboratories quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Bio-Rad Laboratories?
  • What is Bio-Rad Laboratories quarterly long term liabilities year-on-year change?

What is Bio-Rad Laboratories annual total long term liabilities?

The current annual total long term liabilities of BIO is $2.33 B

What is the all time high annual total long term liabilities for Bio-Rad Laboratories?

Bio-Rad Laboratories all-time high annual total long term liabilities is $3.43 B

What is Bio-Rad Laboratories annual total long term liabilities year-on-year change?

Over the past year, BIO annual total long term liabilities has changed by -$708.10 M (-23.33%)

What is Bio-Rad Laboratories quarterly total long term liabilities?

The current quarterly long term liabilities of BIO is $2.33 B

What is the all time high quarterly long term liabilities for Bio-Rad Laboratories?

Bio-Rad Laboratories all-time high quarterly total long term liabilities is $3.97 B

What is Bio-Rad Laboratories quarterly long term liabilities year-on-year change?

Over the past year, BIO quarterly total long term liabilities has changed by -$765.61 M (-24.76%)